Ignite Creation Date:
2024-05-05 @ 6:34 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00503347
Status:
COMPLETED
Last Update Posted:
2011-06-09
First Post:
2007-07-16
Brief Title:
Bavituximab Repeat-Dose Trial in Patients Co-Infected With Chronic Hepatitis C Virus and Human Immunodeficiency Virus
Sponsor:
Organization:
Peregrine Pharmaceuticals